Furthermore, luteolin reduces PCNA expression and the Wnt-target gene Cyclin D1 protein level, reducing the proliferation of tumors caused by the AOM/DSS protocol by modulating the localization of β-catenin in mice treated with a single dose with 1.2 mg/kg body weight [111]. This evidence concerns the gene CCND1 and infectious otitis media.